These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 18789793)

  • 21. Lowering of IOP by echothiophate iodide in pseudophakic eyes with glaucoma.
    Schmidt KG; Horowitz Y; Buckman G; Segev E; Levinger E; Geyer O
    Curr Eye Res; 2010 Aug; 35(8):698-702. PubMed ID: 20673046
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics and metabolism of anecortave acetate in animals and humans.
    Dahlin DC; Rahimy MH
    Surv Ophthalmol; 2007 Jan; 52 Suppl 1():S49-61. PubMed ID: 17240257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anecortave acetate treatment for retinal angiomatous proliferation: a pilot study.
    Klais CM; Eandi CM; Ober MD; Sorenson JA; Sadeghi SN; Freund KB; Spaide RF; Slakter JS; Yannuzzi LA
    Retina; 2006 Sep; 26(7):773-9. PubMed ID: 16963850
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prospective study of early intraocular pressure changes after a single intravitreal triamcinolone injection.
    Im L; Allingham RR; Singh I; Stinnett S; Fekrat S
    J Glaucoma; 2008 Mar; 17(2):128-32. PubMed ID: 18344759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of dorzolamide 2% added to timolol maleate 0.5% on intraocular pressure, retrobulbar blood flow, and the progression of visual field damage in patients with primary open-angle glaucoma: a single-center, 4-year, open-label study.
    Martínez A; Sánchez M
    Clin Ther; 2008 Jun; 30(6):1120-34. PubMed ID: 18640468
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical results with the Trabectome for treatment of open-angle glaucoma.
    Minckler DS; Baerveldt G; Alfaro MR; Francis BA
    Ophthalmology; 2005 Jun; 112(6):962-7. PubMed ID: 15882909
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monocular trial of intraocular pressure-lowering medication: a prospective study.
    King AJ; Uppal S; Rotchford AP; Lakshumanan A; Abedin A; Henry E
    Ophthalmology; 2011 Nov; 118(11):2190-5. PubMed ID: 21724262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The safety and efficacy of brinzolamide 1%/timolol 0.5% fixed combination versus dorzolamide 2%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension.
    Manni G; Denis P; Chew P; Sharpe ED; Orengo-Nania S; Coote MA; Laganovska G; Volksone L; Zeyen T; Filatori I; James J; Aung T
    J Glaucoma; 2009; 18(4):293-300. PubMed ID: 19365194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases.
    Wakabayashi T; Oshima Y; Sakaguchi H; Ikuno Y; Miki A; Gomi F; Otori Y; Kamei M; Kusaka S; Tano Y
    Ophthalmology; 2008 Sep; 115(9):1571-80, 1580.e1-3. PubMed ID: 18440643
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical comparison of pascal dynamic contour tonometry and goldmann applanation tonometry in asymmetric open-angle glaucoma.
    Sullivan-Mee M; Halverson KD; Qualls C
    J Glaucoma; 2007 Dec; 16(8):694-9. PubMed ID: 18091457
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of Travoprost and Bimatoprost plus timolol fixed combinations in open-angle glaucoma patients previously treated with latanoprost plus timolol fixed combination.
    Centofanti M; Oddone F; Gandolfi S; Hommer A; Boehm A; Tanga L; Sangermani C; Sportelli V; Haustein M; Manni G; Rossetti L
    Am J Ophthalmol; 2010 Oct; 150(4):575-80. PubMed ID: 20688314
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomised, prospective study comparing selective laser trabeculoplasty with latanoprost for the control of intraocular pressure in ocular hypertension and open angle glaucoma.
    Nagar M; Ogunyomade A; O'Brart DP; Howes F; Marshall J
    Br J Ophthalmol; 2005 Nov; 89(11):1413-7. PubMed ID: 16234442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of lateral decubitus position on intraocular pressure in patients with untreated open-angle glaucoma.
    Lee JY; Yoo C; Kim YY
    Am J Ophthalmol; 2013 Feb; 155(2):329-335.e2. PubMed ID: 23111175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anecortave acetate for the treatment of idiopathic perifoveal telangiectasia: a pilot study.
    Eandi CM; Ober MD; Freund KB; Klais CM; Slakter JS; Sorenson JA; Yannuzzi LA
    Retina; 2006 Sep; 26(7):780-5. PubMed ID: 16963851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in anterior chamber depth and intraocular pressure after phacoemulsification in eyes with occludable angles.
    Shin HC; Subrayan V; Tajunisah I
    J Cataract Refract Surg; 2010 Aug; 36(8):1289-95. PubMed ID: 20656150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intraocular pressure-lowering efficacy of brinzolamide when added to travoprost/timolol fixed combination as adjunctive therapy.
    Goldberg I; Crowston JG; Jasek MC; Stewart JA; Stewart WC;
    J Glaucoma; 2012 Jan; 21(1):55-9. PubMed ID: 21048504
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Prospective, randomized, investigator-masked evaluation of the monocular trial in ocular hypertension or open-angle glaucoma.
    Realini TD
    Ophthalmology; 2009 Jul; 116(7):1237-42. PubMed ID: 19576495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. One-year follow-up of selective laser trabeculoplasty in open-angle glaucoma.
    Cvenkel B
    Ophthalmologica; 2004; 218(1):20-5. PubMed ID: 14688431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A 6-week, multicenter, randomized, double-masked, parallel-group study comparing travoprost 0.004% to latanoprost 0.005% followed by 6-week, open-label treatment with travoprost 0.004%.
    Maul E; Carrasco FG; Costa VP; Casiraghi JF; Vargas E; Sarmina JS; Mayol R
    Clin Ther; 2007 Sep; 29(9):1915-23. PubMed ID: 18035191
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ocular hypotensive efficacy of bimatoprost 0.03% and travoprost 0.004% in patients with glaucoma or ocular hypertension.
    Cantor LB; WuDunn D; Cortes A; Hoop J; Knotts S
    Surv Ophthalmol; 2004 Mar; 49 Suppl 1():S12-8. PubMed ID: 15016557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.